Cited by 52Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity Disorder

Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity

Open access
Jenson, Daniel, Yang, Kechun, Acevedo-Rodriguez, Alexandra, Levine, Amber, Broussard, John I., Tang, Jianrong, Dani, John A.·2015·Neuropharmacology

Abstract

Attention-deficit hyperactive disorder (ADHD) is the most commonly studied and diagnosed psychiatric disorder in children. Methylphenidate (MPH, e.g., Ritalin) has been used to treat ADHD for over 50 years. It is the most commonly prescribed treatment for ADHD, and in the past decade it was the drug most commonly prescribed to teenagers. In addition, MPH has become one of the most widely abused drugs on college campuses. In this study, we examined the effects of MPH on hippocampal synaptic plasticity, which serves as a measurable quantification of memory mechanisms. Field potentials were recorded with permanently implanted electrodes in freely-moving mice to quantify MPH modulation of perforant path synaptic transmission onto granule cells of the dentate gyrus. Our hypothesis was that MPH affects hippocampal synaptic plasticity underlying learning because MPH boosts catecholamine signaling by blocking the dopamine and norepinephrine transporters (DAT and NET respectively). In vitro hippocampal slice experiments indicated MPH enhances perforant path plasticity, and this MPH enhancement arose from action via D1-type dopamine receptors and β-type adrenergic receptors. Similarly, MPH boosted in vivo initiation of long-term potentiation (LTP). While there was an effect via both dopamine and adrenergic receptors in vivo, LTP induction was more dependent on the MPH-induced action via D1-type dopamine receptors. Under biologically reasonable experimental conditions, MPH enhances hippocampal synaptic plasticity via catecholamine receptors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2014.10.029

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Drugs of abuse, such as nicotine and methylphenidate, recruit dopaminergic neurotransmission to influence synaptic plasticity within the hippocampus.

    “Also, there is functional evidence that indicates that drugs of abuse, such as nicotine (Tang and Dani, 2009; Zhang et al., 2010) and methylphenidate (Jenson et al., 2015), recruit dopaminergic neurotransmission to influence synaptic plasticity within the hippocampus.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Hoffman BB Lefkowitz RJ 1996 Goodman and Gilman’s The pharmacological basis of therapeutics, Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists McGraw-Hill New York

Cited by

Sorted by citations

Authors
Jenson, D., Yang, K., Acevedo-Rodriguez, A., Levine, A., Broussard, J. I., Tang, J., & Dani, J. A.
Affiliations
  • Baylor College of Medicine (US)
  • University of Pennsylvania (US)
Corresponding author
Dani, John A.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2015-03
Volume
90
Pages
23-32
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2088570852
Cited by
52
References
86
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 4 · 2016: 9 · 2015: 3
FWCI
2.44
Type
journal article
Language
en
Open access
Locations
  • Neuropharmacology (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (NIDA DA09411, NINDS NS21229)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Keywords
methylphenidate, hippocampal synaptic plasticity, long-term potentiation, dopamine D1 receptor, beta-adrenergic receptors, catecholamine signaling, dopamine transporter, norepinephrine transporter, perforant path, dentate gyrus granule cells, attention deficit hyperactivity disorder, memory, field potentials
MeSH terms
Central Nervous System Stimulants, Animals, Dopamine, Dose-Response Relationship, Drug, Electric Stimulation, Electrodes, Implanted, Female, Male, Methylphenidate, Mice, Inbred C57BL, Neurons, Receptors, Adrenergic, Receptors, Dopamine, Theta Rhythm, Long-Term Potentiation, Patch-Clamp Techniques, Dentate Gyrus, Perforant Pathway, Tissue Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review